Phylogenetic Analysis of Dysbiosis in Ulcerative Colitis During Remission

Background:Presence of intestinal microbes is a prerequisite for the development of ulcerative colitis (UC), although deviation of the normal intestinal microbiota composition, dysbiosis, is presumably implicated in the etiology of UC. Methods:The fecal microbiota of 30 UC samples obtained from 15 patients who were sampled twice and from 15 healthy control subjects originating from 2 geographic locations was analyzed using highly reproducible phylogenetic microarray that has the capacity for detection and quantification of more than 1000 intestinal bacteria in a wide dynamic range. Results:The fecal microbiota composition is not significantly influenced by geographic location, age, or gender, but it differs significantly between the patients with UC and the control subjects (P = 0.0004). UC-associated microbiota is stable during remission and similar among all patients with UC. Significant reduction of bacterial diversity of members of the Clostridium cluster IV and significant reduction in the abundance of bacteria involved in butyrate and propionate metabolism, including Ruminococcus bromii et rel. Eubacterium rectale et rel., Roseburia sp., and Akkermansia sp. are markers of dysbiosis in UC. Increased abundance of (opportunistic) pathogens including Fusobacterium sp., Peptostreptococcus sp., Helicobacter sp., and Campylobacter sp. as well as Clostridium difficile were found to be associated with UC. Conclusions:Dysbiosis in UC is stable in time and shared between patients from different geographic locations. The microbial alterations offer a mechanistic insight into the pathogenesis of the disease.

[1]  Dan Turner,et al.  Alterations in the gut microbiome of children with severe ulcerative colitis , 2012, Inflammatory bowel diseases.

[2]  S. Lynch,et al.  Role of the microbiota in inflammatory bowel diseases. , 2012, Inflammatory bowel diseases.

[3]  W. M. Vos,et al.  Microbes inside—from diversity to function: the case of Akkermansia , 2012, The ISME Journal.

[4]  B. Birren,et al.  Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. , 2012, Genome research.

[5]  Richard A. Moore,et al.  Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. , 2012, Genome research.

[6]  Liping Zhao,et al.  Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers , 2011, The ISME Journal.

[7]  W. D. de Vos,et al.  Modulation of Mucosal Immune Response, Tolerance, and Proliferation in Mice Colonized by the Mucin-Degrader Akkermansia muciniphila , 2011, Front. Microbio..

[8]  E. El-Omar,et al.  Detection of Campylobacter concisus and Other Campylobacter Species in Colonic Biopsies from Adults with Ulcerative Colitis , 2011, PloS one.

[9]  Richard Hansen,et al.  Enterohepatic Helicobacter in Ulcerative Colitis: Potential Pathogenic Entities? , 2011, PloS one.

[10]  Julian Parkhill,et al.  High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease , 2011, BMC Microbiology.

[11]  E. K. Kemsley,et al.  Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota , 2010, BMC gastroenterology.

[12]  Michael A McGuckin,et al.  Mucolytic Bacteria With Increased Prevalence in IBD Mucosa Augment In Vitro Utilization of Mucin by Other Bacteria , 2010, The American Journal of Gastroenterology.

[13]  S. Taylor-Robinson,et al.  Differences in gut microbial metabolism are responsible for reduced hippurate synthesis in Crohn's disease , 2010, BMC gastroenterology.

[14]  Frans Schuit,et al.  Impaired butyrate oxidation in ulcerative colitis is due to decreased butyrate uptake and a defect in the oxidation pathway* , 2010, Inflammatory bowel diseases.

[15]  M. Weizenegger,et al.  Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum/necrophorum , 2009, Gut.

[16]  R. Xavier,et al.  Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43 , 2009, Nature.

[17]  Martin Täubel,et al.  The occupant as a source of house dust bacteria. , 2009, The Journal of allergy and clinical immunology.

[18]  W. D. de Vos,et al.  Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults , 2009, Environmental microbiology.

[19]  D. Jewell,et al.  Characterization of Inflammatory Bowel Disease With Urinary Metabolic Profiling , 2009, The American Journal of Gastroenterology.

[20]  R. P. Ross,et al.  The Vexed Relationship Between Clostridium Difficile and Inflammatory Bowel Disease: An Assessment of Carriage in an Outpatient Setting Among Patients in Remission , 2009, The American Journal of Gastroenterology.

[21]  W. D. de Vos,et al.  Linking phylogenetic identities of bacteria to starch fermentation in an in vitro model of the large intestine by RNA-based stable isotope probing. , 2009, Environmental microbiology.

[22]  E. Zoetendal,et al.  High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota , 2008, Gut.

[23]  M. Spehlmann,et al.  Epidemiology of inflammatory bowel disease in a German twin cohort: Results of a nationwide study , 2008, Inflammatory bowel diseases.

[24]  H. Ogata,et al.  Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease. , 2008, International journal of medical microbiology : IJMM.

[25]  C. Bernstein,et al.  Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases , 2008, Gut.

[26]  S. Mazmanian,et al.  A microbial symbiosis factor prevents intestinal inflammatory disease , 2008, Nature.

[27]  Miia Pitkäranta,et al.  Diversity and seasonal dynamics of bacterial community in indoor environment , 2008, BMC Microbiology.

[28]  M. Rantalainen,et al.  Symbiotic gut microbes modulate human metabolic phenotypes , 2008, Proceedings of the National Academy of Sciences.

[29]  Seppo Salminen,et al.  The Mucin Degrader Akkermansia muciniphila Is an Abundant Resident of the Human Intestinal Tract , 2007, Applied and Environmental Microbiology.

[30]  Hauke Smidt,et al.  Diversity of the human gastrointestinal tract microbiota revisited. , 2007, Environmental microbiology.

[31]  N. Pace,et al.  Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases , 2007, Proceedings of the National Academy of Sciences.

[32]  S. Tedelind,et al.  Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. , 2007, World journal of gastroenterology.

[33]  P. Mannon,et al.  The fundamental basis of inflammatory bowel disease. , 2007, The Journal of clinical investigation.

[34]  I. Wilson,et al.  Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. , 2007, Journal of proteome research.

[35]  Michiel Kleerebezem,et al.  Isolation of DNA from bacterial samples of the human gastrointestinal tract , 2006, Nature Protocols.

[36]  S. Miehlke,et al.  Prevalence of Bacteroides and Prevotella spp. in ulcerative colitis. , 2006, Journal of medical microbiology.

[37]  F. Guarner,et al.  Mechanisms of Disease: the hygiene hypothesis revisited , 2006, Nature Clinical Practice Gastroenterology &Hepatology.

[38]  Philippe Marteau,et al.  Specificities of the fecal microbiota in inflammatory bowel disease , 2006, Inflammatory bowel diseases.

[39]  H. Lochs,et al.  Spatial Organization and Composition of the Mucosal Flora in Patients with Inflammatory Bowel Disease , 2005, Journal of Clinical Microbiology.

[40]  Eddie J. B. van Etten,et al.  Multivariate Analysis of Ecological Data Using canoco , 2005 .

[41]  D. Rampton,et al.  Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool , 2004, European journal of gastroenterology & hepatology.

[42]  G. Macfarlane,et al.  Chemotaxonomic analysis of bacterial populations colonizing the rectal mucosa in patients with ulcerative colitis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[43]  T. Karasawa,et al.  Clostridium difficile colonization in healthy adults: transient colonization and correlation with enterococcal colonization. , 2004, Journal of medical microbiology.

[44]  J. Lepš,et al.  Multivariate Analysis of Ecological Data using CANOCO: Preface , 2003 .

[45]  T. Ohkusa,et al.  Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis , 2003, Gut.

[46]  H. Flint,et al.  Roseburia intestinalis sp. nov., a novel saccharolytic, butyrate-producing bacterium from human faeces. , 2002, International journal of systematic and evolutionary microbiology.

[47]  Wold,et al.  Increased Antibody Production against Gut‐Colonizing Escherichia coli in the Presence of the Anaerobic Bacterium Peptostreptococcus , 1998, Scandinavian journal of immunology.

[48]  R. Pounder,et al.  A simple clinical colitis activity index , 1998, Gut.

[49]  W. Babidge,et al.  Colonic Sulfide in Pathogenesis and Treatment of Ulcerative Colitis , 1997, Digestive Diseases and Sciences.

[50]  B. Patel,et al.  Isolation and Characterization of Sporobacter termitidis gen. nov., sp. nov., from the Digestive Tract of the Wood-Feeding Termite Nasutitermes lujae , 1996 .

[51]  P. Lawson,et al.  The phylogeny of the genus Clostridium: proposal of five new genera and eleven new species combinations. , 1994, International journal of systematic bacteriology.

[52]  Boyle,et al.  Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis. , 1994, Gut.

[53]  R. Pounder,et al.  Clostridium difficile and inflammatory bowel disease. , 1983, Gut.

[54]  K. B. Amor.  Microbial Eco-Physiology of the human intestinal tract: a flow cytometric approach , 2004 .

[55]  E. H. Simpson.  Measurement of Diversity , 1949, Nature.